Dr. Reddy's Files for ADR Offering

It's an India-based pharmaceutical firm.
Author:
Publish date:

India-based pharmaceutical firm

Dr. Reddy's Laboratories

(RDY) - Get Report

said Monday that it filed a shelf registration statement on Form F-3 with the SEC relating to a proposed offering of ADSs of up to 13.5 million shares, excluding the underwriter's over-allotment option.

The Form F-3 filed today does not contain any information regarding the terms and conditions of the proposed ADS offering.

The company's shares were trading up 11 cents at $17.57 Monday.

This story was created through a joint venture between TheStreet.com and IRIS.